Work

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Year: 2000

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(00)02841-5

Authors: Jonas Bergh, Tom Wiklund, Björn Erikstein, Elisabet Lidbrink, Henrik Lindman, Per Malmström, Pirkko Kellokumpu-Lehtinen, Nils-Olof Bengtsson, Gustaf Söderlund, Gun Anker, Erik Wist, Susanne Ottosson, Eeva Salminen, Per Ljungman, Harald Holte, Jonas Nilsson, Carl Blomqvist, Nils Wilking

Institutions: Karolinska University Hospital, Helsinki University Hospital, Stockholm South General Hospital, Uppsala University Hospital, Skåne University Hospital, Tampere University Hospital, University Hospital of Umeå, Linköping University Hospital, Haukeland University Hospital, Sahlgrenska University Hospital, Turku University Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2138991012

FWCI: 10.55

Cites: 28

Cited by: 336

Related to: 10